Risperidone Augmentation for PTSD
Post-Traumatic Stress Disorder
About this trial
This is an interventional treatment trial for Post-Traumatic Stress Disorder focused on measuring PTSD, sertraline, risperidone, antidepressant, antipsychotic, anxiety, trauma
Eligibility Criteria
Inclusion Criteria: Signed consent prior to any study procedures being done Male or female outpatients between 18-65 years of age Trauma experienced meets trauma defined by DSM Meets criteria for DSM-IV PTSD as a result of civilian trauma CAPS Score of greater than or equal to 50 at screening and baseline Able to swallow whole capsules Fluency in both written and spoken English Negative urine drug screen at screening visit If female of childbearing potential, must have negative serum pregnancy test at screening visit and must agree to use a medically accepted means of contraception throughout the study and for 30 days after completion of the study To be include in Phase 2, must complete Phase I and must have less than 70% reduction from baseline on the CAPS Exclusion Criteria: Pregnant women or those likely to become pregnant, or nursing mothers Medical instability (clinically significant hepatic, cardiac, or pulmonary disease, HIV, uncontrolled hypertension, diabetes or thyroid conditions, seizure disorders, clinically significant laboratory abnormalities at screen Primary psychotic disorder, or history of schizophrenia, other psychotic disorder, bipolar disorder, or cognitive disorder Those considered a risk for suicidal or homicidal behavior (the clinician will immediately, upon assessing a risk for suicidal or homicidal behavior, refer the patient for further evaluation and probable hospitalization) Hypersensitivity or other contraindication to sertraline or risperidone Meeting DSM-IV criteria for drug or alcohol dependence within 3 months of study entry Those who are still experiencing an ongoing traumatic stressor (domestic violence/elder abuse) who will need to focus on safety (the clinician will make referrals as appropriate) DSM-IV primary diagnosis of any other anxiety disorder or major depressive disorder Current use of antipsychotic, or other psychotropic medications, or supplements with known psychotropic effects Current involvement in litigation related to PTSD Current psychotherapy aimed at treating PTSD PTSD as a result of combat-related trauma Previous failure to respond to sertraline-risperidone combination at therapeutic dose
Sites / Locations
- Emory University Medical Center
- Medical University of South Carolina